Exelixis, Inc.

EXEL · NASDAQ
Analyze with AI
1/3/2025
12/31/2023
12/31/2022
12/31/2021
Revenue$2,168,701$1,830,208$1,611,062$1,434,970
% Growth18.5%13.6%12.3%
Cost of Goods Sold$76,216$72,547$57,909$52,873
Gross Profit$2,092,485$1,757,661$1,553,153$1,382,097
% Margin96.5%96%96.4%96.3%
R&D Expenses$910,408$1,044,071$891,813$693,716
G&A Expenses$492,128$542,705$418,256$369,915
SG&A Expenses$492,128$542,705$459,856$401,715
Sales & Mktg Exp.$0$0$41,600$31,800
Other Operating Expenses$85,332$0-$197-$184
Operating Expenses$1,487,868$1,586,776$1,351,669$1,095,431
Operating Income$604,617$170,885$201,484$286,666
% Margin27.9%9.3%12.5%20%
Other Income/Exp. Net$77,023$86,636$32,868$7,488
Pre-Tax Income$681,640$257,521$234,352$294,154
Tax Expense$160,373$49,756$52,070$63,091
Net Income$521,267$207,765$182,282$231,063
% Margin24%11.4%11.3%16.1%
EPS1.80.650.570.73
% Growth176.9%14%-21.9%
EPS Diluted1.760.650.560.72
Weighted Avg Shares Out290,030318,151321,526314,884
Weighted Avg Shares Out Dil296,132321,464324,556322,359
Supplemental Information
Interest Income$77,156$86,543$33,065$7,672
Interest Expense$0$0$0$0
Depreciation & Amortization$28,803$25,717$20,875$13,630
EBITDA$718,752$196,602$222,359$300,296
% Margin33.1%10.7%13.8%20.9%